FUNDING ROUND open on march 2023

all the information here

We aim to finance Phase III clinical trials for brain tumor treatment. Previous funding round closed for a total of 3.1 million euros

For more information about this investment opportunity


You can also find the information about the last

Crowdfunding for Laminar Pharma at Capital Cell

finished successfully in July 2022.

Company News

Scientific publications